Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Adams & AdamsJenny Pienaar and Nicole Haworth of Adams & Adams discuss the potential implications of South Africa's divisive R3337 food labelling bill in an exclusive podcast
-
Sponsored by Saint Island International Patent & Law OfficesFiona Yin of Saint Island International Patent & Law Offices provides a guide to the considerations for patent applicants in deciding when to submit a divisional application
-
Sponsored by Maiwald Intellectual PropertyIn concluding a two-part series on springboard injunctions, Marco Stief of Maiwald takes a deeper dive to explain their requirements, review case law, and examine their relevance in the pharmaceutical and life sciences sectors
-
Sponsored by CCPIT Patent and Trademark Law OfficeIn the final part of a three-part series, Managing IP sat down with Chuanhong Long, president of CCPIT Patent and Trademark Law Office, to discuss the latest crucial developments in China’s IP landscape, this time analysing the impact of recent court decisions on OEM IP issues
-
Sponsored by Spoor & FisherMatthew Costard and Nola Pontes of Spoor & Fisher Jersey look at some of the issues that arise with trademark searching in countries that form the continent of Africa
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula of RNA discusses the complex and controversial relationship between Indian personality rights and AI-generated fake content